Stay up-to-date with the Dr. Reddy's Laboratories Stock Liveblog, your comprehensive source for real-time updates and ...

Osteoarthritis is a severe but manageable condition. Working closely with healthcare professionals and formulating ...

An analyst from Centrum Broking said that Dr Reddy's Labs is in a downtrend and witnessing a constant supply at the higher ...

Recognizing the early warning signs of OA and understanding its progression is crucial for early intervention and effective ...

Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.26% to 6,630.85 Indian rupees Tuesday, on what proved to be an ...

The head of India's market regulator and her husband are answering allegations of conflict of interest raised by the main ...

Facing off against oral drugs such as AbbVie’s Ubrelvy, Tonix is seeking to raise awareness of potential benefits of nasal ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.38% to 6,658.60 Indian rupees Friday, on what proved to be an ...

Indian automaker Mahindra & Mahindra and pharmaceutical company Dr Reddy's Laboratories said on Tuesday they had paid the ...

Dr Reddy’s Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in multiple strengths, the US health regulator said in its latest enforcement report.

Dr. Reddy's Laboratories and Lupin are pulling back their pharmaceutical products from the US market, following manufacturing deficiencies highlighted by the US Food and Drug Administration (USFDA).